The PI3K/Akt Pathway as a Target in the Treatment of Hematologic Malignancies

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|9|5|550-559

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.9, Iss.5, 2009-06, pp. : 550-559

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulation and Importance of the PI3K/Akt/mTOR Signaling Pathway in Hematologic Malignancies

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 9, 2009-11 ,pp. : 1024-1038

Bentham Science Publishers

Access to resources Recommend Favorite

PI3K/Akt signaling pathway is involved in the neurotrophic effect of senegenin

By                

Molecular Medicine Reports, Vol. 13, Iss. 2, 2016-01 ,pp. : 1257-1262

Spandidos Publications

Access to resources Recommend Favorite

The Effect of Lycopene on the PI3K/Akt Signalling Pathway in Prostate Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 6, 2014-01 ,pp. : 800-805

Bentham Science Publishers

Access to resources Recommend Favorite

Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells

By      

International Journal of Oncology, Vol. 46, Iss. 6, 2015-01 ,pp. : 2355-2363

Spandidos Publications

Access to resources Recommend Favorite

Shikonin promotes autophagy in BXPC3 human pancreatic cancer cells through the PI3K/Akt signaling pathway

By    

Oncology Letters, Vol. 8, Iss. 3, 2014-01 ,pp. : 1087-1089

Spandidos Publications

Access to resources Recommend Favorite